Literature DB >> 5621485

Envelope protein of influenza virus. I. Hemagglutinating activity of reassociated subunits.

E A Eckert.   

Abstract

The hemagglutinating properties of influenza virus envelope protein, prepared by reassociation of polypeptide subunits, have been defined and compared with those of virus and ether-split hemagglutinin. In general, the characteristics of the intact and ether-split virus were found to be similar, whereas those of the envelope protein were distinctly different. The use of chicken, pigeon, and guinea pig erythrocytes both at 23 and 4 C disclosed that the hemagglutinating titers of envelope protein preparations were particularly dependent on the system employed. Under optimal conditions, with guinea pig cells at 4 C, the titers of envelope protein preparations were equivalent to those of the original virus concentrates. The hemagglutinating activity of envelope protein was particularly sensitive to elevated temperature, concentrated urea, sulfhydryl-reducing reagents, and tryptic digestion at high salt concentrations. In all these respects, the intact virus was more resistant than the envelope protein. Interpretation of the data indicates that the hemagglutinin is stabilized when associated with the lipid micelle at the surface of the virus.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5621485      PMCID: PMC375370     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  9 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  EFFECT OF UREA ON A2 INFLUENZA VIRUS.

Authors:  D C DORMAN
Journal:  Nature       Date:  1964-08-15       Impact factor: 49.962

3.  INTERACTIONS OF ETHER-DISRUPTED INFLUENZA A2 VIRUS WITH ERYTHROCYTES, INHIBITORS, AND ANTIBODIES.

Authors:  P W CHOPPIN; W STOECKENIUS
Journal:  Virology       Date:  1964-04       Impact factor: 3.616

4.  SEROLOGIC AND ANTIGENIC PROPERTIES OF TYPE A INFLUENZA VIRUS AFTER TRYPSIN TREATMENT.

Authors:  R CLEELAND; J Y SUGG
Journal:  J Immunol       Date:  1964-09       Impact factor: 5.422

5.  The structure and composition of the myxoviruses. II. Components released from the influenza virus particle by ether.

Authors:  L HOYLE; R W HORNE; A P WATERSON
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

6.  The structural relationship of sialidase to the influenza virus surface.

Authors:  H NOLL; T AOYAGI; J ORLANDO
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

7.  Isolation of a low molecular weight sialidase (neuraminidase) from influenza virus.

Authors:  R Seto JT BRZENIEK; R Rott
Journal:  Biochim Biophys Acta       Date:  1966-02-14

8.  Envelope protein(s) derived from influenza virus.

Authors:  E A Eckert
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

9.  Characterization of a low molecular weight antigenic protein from the envelope of influenza virus.

Authors:  E A Eckert
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

  9 in total
  6 in total

1.  The selective inactivation of influenza virus haemagglutinin by pyridine.

Authors:  F Biddle; A P Kendal
Journal:  Arch Gesamte Virusforsch       Date:  1971

2.  Thermal inactivation of Newcastle disease virus. I. Coupled inactivation rates of hemagglutinating and neuraminidase activities.

Authors:  J S Pierce; A M Haywood
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

3.  The chemical reactions of the haemagglutinins and neuraminidases of different strains of influenza viruses. II. Effects of reagents modifying the higher order structure of the protein molecule.

Authors:  L Hoyle
Journal:  J Hyg (Lond)       Date:  1969-06

4.  Inactivation of the hemagglutinins of type A influenza viruses by physical and chemical means: an aid to classification.

Authors:  R Cleeland; E Grunberg; H N Prince
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

5.  Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo.

Authors:  Dongxi Xiang; Yang Zheng; Wei Duan; Xiujing Li; Jianjian Yin; Sarah Shigdar; Michael Liam O'Connor; Manju Marappan; Xiaojuan Zhao; Yingqiu Miao; Bin Xiang; Conglong Zheng
Journal:  Int J Nanomedicine       Date:  2013-10-30

Review 6.  Virus-erythrocyte interactions.

Authors:  C Howe; L T Lee
Journal:  Adv Virus Res       Date:  1972       Impact factor: 9.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.